<div id="readability-page-1">High court decision: The Supreme Court refused to hear petitions from six drugmakers challenging Medicare’s drug price negotiations. Projected savings: Negotiated prices are expected to save patients $1.5 billion and Medicare $6 billion in the first year. Legal battles continue: Separate lawsuits are still pending in lower courts, potentially setting up future Supreme Court review.</div>

PILL

<p>The Supreme Court declined to hear appeals from six drugmakers against Medicare's drug price negotiations. This decision is projected to save patients $1.5 billion and Medicare $6 billion in the first year. Ongoing legal challenges in lower courts may lead to future Supreme Court reviews.</p>

Supreme Court rejects drugmakers’ bid to halt Medicare price talks